Literature DB >> 8714273

Rapid and sensitive detection of anti-Ro (SS-A) antibodies by indirect immunofluorescence of 60kDa Ro HEp-2 transfectants.

C L Keech1, S Howarth, T Coates, M Rischmueller, J McCluskey, T P Gordon.   

Abstract

Anti-Ro (SS-A) antibodies are important diagnostic markers for primary Sjögren's syndrome and systemic lupus erythematosus, but their detection by indirect immunofluorescence (IF) in the diagnostic laboratory is hindered by the low cellular abundance of 60kDa Ro protein (Ro60). The approach we used to overcome this problem was to transfect and over-express the Ro60 gene into HEp-2 cells. In this study we have used a mixture of Ro60 transfectants and untransfected HEp-2 cells (HEp-Ro60) as a substrate for IF-antinuclear antibody (ANA) testing in a hospital laboratory. Screening of 240 routine serum specimens identified 14 Ro transfectant-positive sera which were confirmed by counterimmunoelectrophoresis (CIE); 3 of these sera were ANA-negative on untransfected cells and regular HEp-2. A comparison of HEp-Ro60 and regular HEp-2 showed strong concordance of the different ANA patterns between the 2 substrates. No increase in background staining was observed on the Ro transfectants when reacted with normal human sera. A comparison between HEp-Ro60 and CIE for 53 sera from patients with primary Sjögren's syndrome showed that HEp-Ro60 were a sensitive and specific substrate for detection of anti-Ro antibodies. Masking of positive Ro transfectants was observed rarely in sera containing multiple ANA specificities, but the Ro60 staining on these transfectants were unmasked at higher serum dilutions. We conclude that HEp-Ro60 are a suitable substrate for IF-ANA in the routine laboratory and that they have the additional advantage over regular HEp-2 slides of being able to detect anti-Ro in ANA-negative sera. HEp-RO60 are also a valuable confirmatory test for sera giving equivocal precipitin reactions or ELISA results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8714273     DOI: 10.1080/00313029600169533

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  8 in total

1.  Antinuclear antibody (ANA) profile testing of ANA- positive patients.

Authors:  G S Hauksdóttir; T Jónsson; O J Mellbye
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

2.  Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate.

Authors:  Marvin J Fritzler; Cheryl Hanson; Joan Miller; Theophany Eystathioy
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.

Authors:  W Pollock; B H Toh
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

4.  Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Authors:  May Y Choi; Ann E Clarke; Yvan St Pierre; John G Hanly; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; Mary A Dooley; Paul R Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Susan Manzi; Ola Nived; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Thomas Stoll; Jill Buyon; Michael Mahler; Marvin J Fritzler
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-06-12       Impact factor: 4.794

5.  Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System.

Authors:  Lisa Anne Davis; Barbara Goldstein; Vivian Tran; Angela Keniston; Jinoos Yazdany; Joel Hirsh; Amy Storfa; JoAnn Zell
Journal:  Open Rheumatol J       Date:  2015-11-04

6.  Identification of a unique anti-Ro60 subset with restricted serological and molecular profiles.

Authors:  A Y S Lee; D Beroukas; L Brown; C Lucchesi; A Kaur; L Gyedu; N Hughes; Y H Ng; O Saran; T P Gordon; J J Wang
Journal:  Clin Exp Immunol       Date:  2020-09-17       Impact factor: 4.330

7.  Origin and diversification of TRIM ubiquitin ligases.

Authors:  Ignacio Marín
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein.

Authors:  Bing Zheng; Rodrigo A Mora; Marvin J Fritzler; Minoru Satoh; Donald B Bloch; Ignacio Garcia-De La Torre; Katherine Boylan; Kathryn Kohl; Mark H Wener; Luis E C Andrade; Edward K L Chan
Journal:  Clin Chem Lab Med       Date:  2020-08-10       Impact factor: 3.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.